Fineotex Chemical Limited (FCL) AI Stock Analysis

Fineotex Chemical Limited

(NSE:FCL)

Select Model

Rating:61.6Neutral

Price Target:INR 51.00▲(4.96% Upside)

Action:reiterated

Date:10/07/26

The overall score reflects a company with a fortress-like balance sheet and strong price momentum, but significant fundamental headwinds. The primary drag is the combination of declining profitability margins, negative cash flows, and a very high P/E ratio, which together create substantial downside risk if operational improvements do not materialize. The bullish technical trend provides near-term support, but the rich valuation leaves little room for error.

Positive Factors

Strong Revenue GrowthThe sharp FY2026 rebound, following several years of expansion, indicates meaningful demand for FCL’s specialty textile chemicals across its processing-focused customer base. Continued top-line growth can improve operating leverage, support product investment, and strengthen the company’s position in its served markets over the next several quarters.

Negative Factors

Weak Recent Cash ConversionThe reversal from strong operating cash generation in FY2023-FY2025 to negative operating cash flow in FY2026 creates a meaningful gap between accounting profits and cash realization. If sustained, this could increase reliance on balance-sheet flexibility and limit the funds available for expansion, dividends, or other capital allocation.

Fineotex Chemical Limited (FCL) vs. iShares MSCI India ETF (INDA)

Market Cap: INR 56.35B
Dividend Yield: 0.27%
Average Volume (3M): 1.40M
Price to Earnings (P/E): 40.3
Beta (1Y): 1.22
Revenue Growth: 91.44%
EPS Growth: 19.67%
Country: India
Employees: 214
Sector: General
Sector Strength: 55
Industry: Chemicals - Specialty

Fineotex Chemical Limited Business Overview & Revenue Model

Company Description

Founded in 1979 and based in Mumbai, India, Fineotex Chemical Limited is a global manufacturer and distributor of a broad spectrum of specialty and auxiliary chemicals. The company develops tailored chemical solutions for the textile industry, coveri...

How the Company Makes Money

FCL primarily makes money by selling specialty textile chemicals to industrial customers (e.g., textile processors, dyeing and finishing units, and garment-related processing facilities). Revenue is generated from (i) product sales of chemical formul...

Fineotex Chemical Limited Financial Statement Overview

Summary

Mixed financials: Strong revenue growth (+48% in FY2026) and an exceptionally robust balance sheet (debt-to-equity <1%) are offset by margin compression (gross margin down to 26%) and negative operating cash flow (-₹222M). The solid equity base provides resilience, but deteriorating profitability and cash generation weigh on the score.

Income Statement

62Positive

Balance Sheet

85Very Positive

Cash Flow

45Neutral

Financial statement breakdown
Breakdown	TTM	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Income Statement
Total Revenue	10.12B	7.72B	5.33B	5.69B	5.17B	3.67B
Gross Profit	2.76B	2.01B	2.06B	2.17B	1.78B	1.30B
EBITDA	1.96B	1.68B	1.52B	1.65B	1.13B	767.24M
Net Income	1.22B	1.09B	1.08B	1.20B	883.16M	551.74M
Balance Sheet
Total Assets	0	11.59B	8.15B	5.48B	4.22B	3.39B
Cash, Cash Equivalents and Short-Term Investments	732.33M	732.33M	330.01M	735.06M	611.90M	308.35M
Total Debt	0	81.96M	2.17M	51.90M	72.80M	19.08M
Total Liabilities	-9.40B	2.19B	757.59M	945.90M	659.02M	700.96M
Stockholders Equity	9.40B	8.82B	7.31B	4.47B	3.49B	2.62B
Cash Flow
Free Cash Flow	81.22M	-476.20M	-73.46M	494.76M	887.62M	-91.37M
Operating Cash Flow	200.95M	-222.29M	693.34M	973.81M	1.08B	133.75M
Investing Cash Flow	-51.66M	987.46M	-2.73B	-468.50M	-1.03B	-7.44M
Financing Cash Flow	-49.37M	-611.54M	1.76B	-239.11M	-64.39M	-56.59M

Fineotex Chemical Limited Technical Analysis

Technical Analysis SentimentNegative

Last Price48.59

Price Trends

50DMA53.66Negative

100DMA46.91Positive

200DMA36.13Positive

Market Momentum

MACD-1.46Positive

RSI39.75Neutral

STOCH26.05Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:FCL, the sentiment is Negative. The current price of 48.59 is below the 20-day moving average (MA) of 54.23, below the 50-day MA of 53.66, and above the 200-day MA of 36.13, indicating a neutral trend. The MACD of -1.46 indicates Positive momentum. The RSI at 39.75 is Neutral, neither overbought nor oversold. The STOCH value of 26.05 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:FCL.

Fineotex Chemical Limited Peers Comparison

Overall Rating

UnderperformOutperform

Sector (55)

Financial Indicators

IN:FCL against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
IN:ROSSARI	65Neutral	INR 22.12B	14.48	―	0.13%	19.76%	11.74%
IN:FCL	62Neutral	INR 56.58B	40.33	―	0.27%	91.44%	19.67%
IN:BALAMINES	58Neutral	INR 57.16B	27.90	―	0.63%	11.08%	34.10%
IN:BODALCHEM	57Neutral	INR 20.74B	30.19	―	―	27.57%	135.05%
Sector *	55Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%
IN:SUDARSCHEM	46Neutral	INR 78.99B	108.61	―	0.96%	90.13%	-6.80%
IN:CAMLINFINE	30Underperform	INR 16.15B	323.46	―	―	8.40%	―

* General Sector Average

Performance Comparison

IN:FCL and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
IN:FCL	Fineotex Chemical Limited	48.59	16.55	51.67%
IN:BALAMINES	Balaji Amines Limited	1764.15	351.10	24.85%
IN:BODALCHEM	Bodal Chemicals Limited	164.70	102.36	164.20%
IN:CAMLINFINE	Camlin Fine Sciences Limited	84.05	-115.70	-57.92%
IN:ROSSARI	Rossari Biotech Ltd	399.25	-242.58	-37.79%
IN:SUDARSCHEM	Sudarshan Chemical Industries Limited	992.15	-150.79	-13.19%

Fineotex Chemical Limited Corporate Events

Fineotex Forms U.S. Step-Down Subsidiary to Drive Specialty Chemicals Expansion

Sep 1, 2026

Fineotex Chemical Limited has expanded its global structure by incorporating a wholly owned step-down subsidiary, Fineotex Holdings Inc., in the U.S. state of Delaware through its existing subsidiary Fineotex Biotex HealthGuard FZE. The new entity, w...

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 07, 2026

Fineotex Chemical Limited AI Stock Analysis